MDRX Latest Quarter's Earnings
| Announce Date | 01/04/2024 |
| EPS Normalized Actual | $0.2 (Miss by $-0.02) |
| EPS GAAP Actual | $0.2 (Miss by $-0.02) |
| Revenue Actual | $0.142672B |
| Revenue Surprise | Beat by $142.672M |
Upcoming Quarter's Earnings
| Announce Date | 09/30/2024 (Pre-Market) |
| EPS Normalized Estimate | $1.53737 |
| EPS GAAP Estimate | $1.53737 |
| Revenue Estimate | $0.4557B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.5426 | 18.34 | 0.51824 | 0.56697 | 0 |
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | 0.2 | 0 | 0.142672B | -158.18% | 0M |
| FQ4 2021 (Dec 2021) | 0.73 | 0.56 | 0.391699B | 29.1% | 4.95M |
| FQ3 2021 (Sep 2021) | 0.13 | 0.13 | 0.369272B | -8.87% | 369.27M |
| FQ2 2021 (Jun 2021) | 0.16 | 0.16 | 0.373714B | -8.7% | 373.71M |
| FQ1 2021 (Mar 2021) | 0.06 | 0.06 | 0.368352B | -13.13% | 368.35M |
| FQ4 2020 (Dec 2020) | 4.51784 | 4.51784 | 0.277734B | -62.38% | 277.73M |
| FQ3 2020 (Sep 2020) | 0.003104 | 0.003104 | 0.40203B | -10.49% | 402.03M |
| FQ2 2020 (Jun 2020) | -0.05 | -0.05 | 0.406223B | -9.41% | 406.22M |
Quarterly Estimates Summary
FQ4 Announce Date
09/30/2024 (Pre-Market)
Consensus EPS Estimates
1.53737
Consensus Revenue Estimates
0.4557B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | 1.53737 | -- | 1.13765 | 1.93709 | 2 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | 0.46B | -- | 0.36B | 0.55B | 20 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | 0.2 | 0.2 | 0 | 0% |
| FQ4 2021 (Dec 2021) | 0.17 | 0.73 | 0.56 | 76.71% |
| FQ3 2021 (Sep 2021) | 0.13 | 0.13 | 100% | |
| FQ2 2021 (Jun 2021) | 0.16 | 0.16 | 100% | |
| FQ1 2021 (Mar 2021) | 0.06 | 0.06 | 100% | |
| FQ4 2020 (Dec 2020) | 4.51784 | 4.51784 | 100% | |
| FQ3 2020 (Sep 2020) | 0.003104 | 0.003104 | 100% | |
| FQ2 2020 (Jun 2020) | -0.05 | -0.05 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | $0.14B | $0.14B | $0M | 0% |
| FQ4 2021 (Dec 2021) | $0.39B | $0.39B | $4.95M | 1.26% |
| FQ3 2021 (Sep 2021) | $0B | $0.37B | $369.27M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0.37B | $373.71M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $0.37B | $368.35M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $0.28B | $277.73M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $0.4B | $402.03M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.41B | $406.22M | 100% |
MDRX Ratings Summary
MDRX Quant Ranking
